Targeted chemo combo trial for Tough-to-Treat colon cancer
NCT ID NCT04689347
Summary
This trial is testing a new combination of chemotherapy drugs for people with a specific type of advanced colorectal cancer that has spread. The treatment is designed for patients whose tumors have certain genetic features. The main goals are to find the safest dose and see if this combination can help control the cancer for longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITINGMilan, Milan, 20133, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Istituto Oncologico Veneto IRCCS
RECRUITINGPadua, PD, 35128, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ospedale Santa Chiara
RECRUITINGPisa, PI, 56126, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.